United States vs Zimbabwe: Coverage of the human papillomavirus vaccine
United States
66
in 2025
Zimbabwe
63
in 2025
United States rank
48th
Zimbabwe rank
51st
Coverage of the human papillomavirus vaccine over time
- United States
- Zimbabwe
How they compare
United States currently reports 66 against 63 in Zimbabwe, a difference of 3.
The two have swapped places 1 time across 7 shared years of data; in 2019 it was Zimbabwe ahead.
United States ranks 48th and Zimbabwe ranks 51st of 85 countries.
Across the 2 decades both report, United States averaged higher in 1 and Zimbabwe in 1.
Head to head by decade
| Decade | United States | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62 | 64 | 2 | Zimbabwe |
| 2020s | 66.33 | 59.67 | 6.67 | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, United States or Zimbabwe?
- United States, at 66 against 63 in Zimbabwe as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between United States and Zimbabwe?
- 3, with United States ahead.
- How many years of comparable data are there for United States and Zimbabwe?
- 7 years are reported by both, from 2019 to 2025.
- How do United States and Zimbabwe rank globally for coverage of the human papillomavirus vaccine?
- United States ranks 48th and Zimbabwe ranks 51st of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.